The thymus, the site of origin of T cell immunity, shapes the repertoire of T cell reactivity through positive selection of developing T cells and prevents autoimmunity through negative selection of autoreactive T cells. Previous studies have demonstrated an important role for the thymus not only in central deletional tolerance, but also in the induction of peripheral tolerance by vascularized renal allografts in juvenile miniature swine recipients. The same protocol did not induce tolerance in thymectomized recipients nor in recipients beyond the age of thymic involution. We subsequently reported that vascularized thymic lobe grafts from juvenile donors were capable of inducing tolerance in thymectomized juvenile hosts. However, the important question remained whether aged, involuted thymus could also induce tolerance if transplanted into thymectomized hosts, which, if true, would imply that thymic involution is not an intrinsic property of thymic tissue but is rather determined by host factors extrinsic to the thymus. We report here that aged, involuted thymus transplanted as a vascularized graft into juvenile recipients leads to rejuvenation of both thymic structure and function, suggesting that factors extrinsic to the thymus are capable of restoring juvenile thymic function to aged recipients. We show furthermore that rejuvenated aged thymus has the ability to induce transplant tolerance across class I MHC barriers. These findings indicate that it may be possible to manipulate thymic function in adults to induce transplantation tolerance after the age of thymic involution.
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aging ͉ miniature swine ͉ thymus T he thymus plays a central role in the development of immunologic tolerance. Thymic epithelial cells and dendritic cells in the thymus are responsible for the induction of central tolerance to self among developing T cells through negative selection. A similar process has been shown to lead to the development of central transplantation tolerance to alloantigens after allogeneic hematopoietic stem cell (HSC) transplantation, because of negative selection by HSC-derived donor dendritic cells that migrate to the host thymus (1) (2) (3) (4) . Finally, the thymus has been shown to be required for the rapid induction of the stable peripheral tolerance that occurs under the influence of a short course of calcineurin inhibitors after allogeneic renal transplantation in miniature swine (5) .
Thymic structure and function decline with age, however, leading by adolescence to a significant reduction in thymic mass and an impaired ability to regenerate normal T cell numbers after T cell depletion (6, 7) . It is not clear whether this thymic involution is an intrinsic property of thymic tissue or is due to the effects of factors extrinsic to the thymus. Likewise, it remains unclear which tolerance-inducing properties of the thymus are affected by its involution.
We have recently established a procedure for vascularized thymic transplantation in MHC inbred miniature swine that permits a transplanted thymus to function immediately after revascularization (8) . We have now used this technique to study the basis of the immunologic consequences of aging on the thymus. For this purpose, we transplanted vascularized thymic lobe (VTL) grafts from aged miniature swine to young animals of the same swine leukocyte antigen (SLA) inbred line (9) . As we report here, these aged, involuted VTL grafts underwent rejuvenation after this procedure and then facilitated the induction of tolerance, suggesting that thymic function is largely controlled by the host environment rather than by the local thymic milieu.
Results
Thymic Involution with Age In Miniature Swine. We first examined the natural course of thymic involution with aging in naive miniature swine (9) . Right cervical thymic lobes were biopsied from 53 naive Massachusetts General Hospital (MGH) miniature swine of different ages. The cortex and medulla in whole biopsy specimens containing at least 10 lobules were subjected to morphometric analysis by using NIH Image (Scion Image) software (10) . Fig. 1A shows a plot of the ratio of cortical to medullary areas (c/m ratio) as a function of age in miniature swine. Fig. 1 B and C shows representative histologic findings of naive thymic tissue at 4 months and 20 months of age, respectively. As shown in this figure, thymi from 4-month-old miniature swine had well defined, thick cortical thymic areas, whereas thymi from 20-month-old animals were consistently involuted. At 4 months of age, at which point peripheral tolerance can readily be induced (11) , pigs had a c/m ratio between 3 and 5, whereas pigs older than 20 months, when such peripheral tolerance could no longer be induced (12) , had c/m ratios of Ϸ0.8 ( Fig. 1 A) . The correlation coefficient between c/m ratio and age (Ϫ0.82) was highly significant (P Ͻ 0.0004). No difference was seen between the thymi of female and male animals.
Rejuvenation of Aged Thymus Grafts in Juvenile Recipients. We next assessed the ability of involuted thymus grafts to rejuvenate and to support thymopoiesis after transplantation into juvenile animals. VTL grafts were harvested from aged pigs (20-21 months of age) and transplanted into MHC-matched, 4-month-old juvenile animals (recipients 1-3) that had been thymectomized 3 weeks earlier.
A 28-day course of FK506 (tacrolimus) was administered to assure that the grafts would not be rejected because of minor antigen differences. FK506 has been found previously not to have measurable effects on thymus structure or involution in miniature swine (13) . The morphometric analysis of aged thymus grafts transplanted into juvenile recipients revealed marked rejuvenation of these grafts within two months of transplantation (Fig. 2) . Aged thymic grafts with an initial c/m ratio of 1 Ϯ 0.3 showed c/m ratios of 3.1 Ϯ 0.8 by 60 days after transplant and 4.1 Ϯ 0.5 by 100 days after transplant. After day 180, the thymic architecture began to rein-volute, with the c/m ratios on day 240 resembling those of recipientage-matched naive animals at these time points (Fig. 2 ). Fig. 3 shows the histology of biopsy specimens from one representative thymectomized juvenile animal (recipient 1) that received an aged thymic graft (c/m ratio of 0.79). By 60 days after transplant, the cortical thymus had markedly expanded with larger lobular structures and well defined cortical and medullary regions (Fig. 3B) . The animal maintained a thymic architecture that resembled that of a juvenile animal until day 180 [ Fig. 3C and supporting information (SI) Fig.  6A ]. By day 240 (SI Fig. 6B ), the cortical thymus of the grafts seemed to be thinner. This reinvolution was likely due to the recipient's age, not to immunologic causes, because the thymi of naive pigs also involute at this age (Fig. 1) .
We stained the thymus biopsy tissues for proliferating cell nuclear antigen (PCNA, a marker of proliferation) and cytokeratin (a marker of thymic epithelial cells) (SI Fig. 6 C-F) , to assess the proliferation of epithelial cells in the VTL graft. The expression of PCNA on cytokeratin-positive cells in both the cortical and medullary regions increased to a maximum on day 100 (SI Fig. 6 D and  F) , indicating that active proliferation of thymic epithelial cells occurred. After day 100, the expression of PCNA decreased in a pattern similar to the expression of PCNA in a naive, age-matched thymus.
Cells dispersed from thymic biopsy tissues were also analyzed by flow cytometry by using allele-specific antibodies. Whereas all of the thymocytes on day 0 were donor-type cells [negative for pig allele-specific antigen (PAA)], most of the thymocytes in the day 60 VTL graft were recipient-type cells (PAA-positive) (SI Fig. 7a ). All thymocytes in the VTL graft were recipient type by day 100. The day 100 analysis revealed a phenotypic pattern similar to that of a naive 4-month-old thymus (SI Fig. 7a) . Furthermore, the FACS profile of the thymocytes from aged thymic grafts on day 60 and thereafter revealed that a majority of the cells were CD4/CD8 double-positive, CD1 highly positive cells that expressed CD3 poorly (SI Fig. 7 b-d ). This profile indicated that the cells in the VTL on day 60 and thereafter were host-type thymocytes derived by thymopoiesis, and not graft infiltrating cells. 
Aged VTLs Induce Transplant Tolerance Across MHC Disparate Barriers but Require a Longer Period of Immunosuppression than Juvenile
VTLs. We subsequently assessed the ability of older thymus grafts to induce tolerance across MHC disparate barriers with the same 28-day course of FK506 that was used across MHC-matched barriers. Based on our previous experience with mouse and porcine thymic transplantations (13, 14) , recipients (recipients 4-6) were completely thymectomized before the transplantation of two haplotype, class I-mismatched VTL grafts. Frequent VTL biopsies were performed on recipient 4 to examine the development of thymopoiesis in the VTL graft. The other two animals received donor-matched kidney grafts on day 100 and third-party kidney grafts Ͼ250 days after VTL transplantation to test in vivo tolerance. Because of previous evidence (15) that thymic biopsies during the induction period may interfere with the induction of transplant tolerance, we did not perform VTL biopsies on these recipients after kidney transplantation until the end of the experimental period. Thymopoiesis. Thymopoiesis was markedly delayed in MHCmismatched VTL grafts as compared with either MHCmatched grafts (see Figs. 2 and 3 and SI Fig. 7 ) or juvenile MHC-mismatched VTLs (13) . Aged MHC-mismatched VTL grafts were still hypocellular on day 60, but thymic stromal cells were present without vasculitis ( Fig. 4 Aa and Ab). However, by day 100, the thymus seemed to have essentially normal, juvenile architecture. The cortex was well developed with dense mononuclear cell migration. The medullary thymus was not as well defined as the cortex, probably because of the stage of thymic development at this time point (Fig. 4 Ac). Immunohistochemistry revealed a small number of recipient-type class I-positive cells in the medullary area (dull brown stained cells), indicating that thymopoiesis occurred between day 60 and 100 ( Fig. 4Ba) .
To assess thymic function at later time points, one animal (recipient 4) that did not receive a renal transplant, underwent serial thymic biopsies on days 150, 180, and 260. The VTL graft biopsies at day 150 and 180 showed markedly expanded thymic lobules with a thick cortical thymic area and well defined medullar structure (Fig. 4Ad) . Recipient-type MHC class I staining showed that the majority of thymocytes in the medullary region of the VTL grafts were of recipient-type (dull brown cells) (Fig. 4Bb) . SI Fig. 8 shows the FACS profile of the VTL graft biopsy on day 180. Consistent with the immunohistochemistry, the majority of cells in the VTL grafts were recipient-type cells as assessed by porcine allele-specific antibody (PAA) (SI Fig. 8b ). FSC/SCC, CD4/CD8, and CD1/CD3 profiles confirmed that these cells were thymocytes, indicating that rejuvenation with active thymopoiesis occurred in the aged VTL graft (SI Fig. 8 a and c-e) . However, in a manner similar to that seen in MHC-matched grafts, the thymus began reinvoluting without evidence of vasculitis after day 260 (Fig. 4Ae) . VTL grafts in the two animals that received kidney transplants were examined when either the third-party kidney was removed or the experiment was terminated (see next section). The VTL graft on day 259 in recipient 5 maintained thymic structure with slight involution, comparable with the animal that did not receive a kidney transplant (recipient 4). Biopsies of VTL grafts on day 310 (recipient 6) and 315 (recipient 5) revealed more obvious involution with fatty degeneration.
In vivo donor-specific tolerance. Two animals, including the animal that had anti-donor CTL responses at day 60 (see below), received donor-matched kidneys without immunosuppression on days 95 (recipient 5) and 105 (recipient 6), respectively. Both animals maintained their grafts for longer than 5 months without any signs of rejection (Fig. 5A, solid lines) . There was no endothelialitis, hemorrhage, or mononuclear cell infiltrate in the kidney grafts at the time of biopsies (days 30, 60, and 153/163 after kidney transplantation) (Fig. 5B ). These two animals received third-party kidneys 163 (recipient 5) and 153 (recipient 6) days after donor- matched kidney transplantation (days 259 and 258 after VTL), respectively, to evaluate immunocompetence. The ureter of the tolerated kidney was tied to permit evaluation of function of the second kidney. Third-party grafts were rejected within 10 days (Fig.  5A , dashed line) with histologic evidence of both cellular and humoral rejection (Fig. 5C ), whereas no rejection was noted in the tolerated kidneys (Fig. 5B) , indicating that aged VTL and 28 days of FK506 had donor-specific tolerance. Both animals were kept alive by untying the ureter of the tolerated kidney when the third-party graft was nephrectomized for in vitro study. The creatinine levels immediately returned to normal, where they remained until euthanization on days 315 and 310 after VTL transplantation.
In vitro assays to determine mechanisms of tolerance. All animals had anti-donor CTL responses Ͼ40% at a 100:1 effector to target ratio before VTL transplantation. Two (recipients 4 and 5) of the three animals developed donor-specific unresponsiveness by day 60 (SI Fig. 9 a and b) . The other animal (recipient 6) maintained anti-donor responses at day 60 (SI Fig. 9c ), thereafter becoming donor-unresponsive by day 120 (SI Fig. 9d ). We further assessed the mechanisms of tolerance in this model by using coculture CTL assays to examine the regulatory mechanisms. Coculture assays were set up on day 60 in recipient 5 and on days Ͼ250 in all three recipients. Donor-specific suppression of the naive T cell response was seen in all of these assays, indicating the presence of regulatory cells in the peripheral blood (SI Fig. 9e from recipient 5 at day 315). In addition, we assessed whether anti-donor CTLs were restored by removal of CD25-positive cells from PBLs from a long-term acceptor on day 315 (recipient 5). The anti-donor CTL response was restored only minimally in the CD25-depleted CML culture (blue solid line compared with blue dashed line in SI Fig. 9f ). Because the CD25 depletion was confirmed by FACS (see Materials and Methods), these data suggest that deletional tolerance mechanisms are also likely to be operative. To further characterize deletional mechanisms, we performed double-staining with donor-type class I phycoerythrin (PE)-conjugated antibody and class II pig-specific FITC-conjugated antibody. At day 100, donor-type class I-positive/class II-positive double-stained morphologically dendritic-like cells (Fig. 4Bd , yellow cells indicated by white arrows) were seen at the corticomedullary junction. In addition, recipient-type morphologically dendritic cells (Fig. 4Bd , green cells that were donor class I-negative but pig class II-positive) migrated to this area by this time point. Donor-type class I-positive, morphologically dendritic-like cells remained at the corticomedullary junction at day 180 (Fig. 4Bc , dense brown cells with arrows). These cells were confirmed to be class II-positive (Fig. 4Be, yellow cells indicated  by white arrows) . Class II-positive recipient-type cells with dendritic cell-like morphology (green cells in Fig. 4 Bd and Be) increased between day 100 and day 180. The coexistence of these donor and recipient cells suggests the potential for host and donor negative selection of T cells in the VTL graft (16) . Inferior ability of aged VTL relative to juvenile VTL to induce tolerance. We have previously shown that VTL grafts from juvenile donors induce tolerance with a 12-day course of FK506 across MHCmismatched barriers in miniature swine. In contrast to a 28-day FK506 regimen, biopsies on day 60 of the VTLs of three animals (recipients 7-9) receiving only 12 days of FK506 revealed mononuclear cells with vasculitis ( SI Fig. 10a ). FACS data indicated that a majority of these cells were CD3-positive with very few CD1-positive cells, a phenotypic pattern similar to that of peripheral blood and indicating the presence of graft infiltrating cells (SI Fig. 10 b and c) . Two of the animals had very few cytokeratin-positive cells in the VTL ( SI Fig. 10d) ; the VTL in the remaining animal (recipient 9) had slightly more cytokeratinpositive epithelial cells (SI Fig. 10e ). All recipients maintained anti-donor CTL responses after VTL transplants (SI Fig. 10f) .
To evaluate the in vivo immunologic status of these recipients, we transplanted donor-matched kidney grafts without immunosuppression to all three animals on day 100. Two animals rejected their renal grafts acutely on days 7 and 15, respectively (SI Fig. 10g ). The third animal, which had a slightly higher number of cytokeratin-positive epithelial cells on day 60, maintained its graft with unstable renal function (Crea 3-6 mg/dl) for 102 days, at which point it was euthanized because of weight loss and renal dysfunction (SI Fig. 10g ). This animal showed signs of acute rejection in the day 30 renal graft biopsy specimen, with diffuse mononuclear cell infiltrates, vasculitis and glomerulitis. A renal biopsy on day 60 revealed chronic glomerulopathy, moderate mononuclear cell infiltrate, and mild fibrosis (SI Fig.  10h ). At the time of euthanization, the renal graft showed moderate interstitial fibrosis, with increased chronic glomerulopathy. The VTL graft at this time point was totally fibrotic. Thus, VTL grafts transplanted from an aged donor to a juvenile recipient with a 12-day course of FK506 prolonged the survival of donor-matched kidney grafts but failed to induce stable tolerance.
Discussion
The thymus plays a central role in the development of T cells and the induction of immunologic tolerance. However, thymic structure and function decline with age, leading by adolescence to a significant reduction in thymic mass and an impaired ability to regenerate normal T cell numbers after T cell depletion (6, 7) . Whereas the age related changes of the thymus are well established, it is not clear whether the involution and decline in function is more dependent on the host environment (extrinsic factors) or on the local thymic milieu (intrinsic factors). Using our model of vascularized thymic lobe transplantation, we transplanted aged thymus into juvenile animals to study the effect of the juvenile milieu on aged thymus (13) . The data presented demonstrate the rejuvenation of aged VTL grafts within juvenile recipients, suggesting that thymic structure and function are more dependent on extrinsic factors than on intrinsic ones. Age-related changes that may affect T cell development occur simultaneously within the bone marrow, the extrathymic milieu, and the thymus (17, 18) . Mackall et al. (19) have reported that the administration of young T cell-depleted bone marrow to lethally irradiated, aged mice failed to reverse thymic involution or histologic abnormalities (including a loss of cortical epithelium and a disruption of the normal cortical architecture) associated with the aged recipient thymus. Although young marrow restored the ability to negatively select autoreactive T cell clones, it did not rejuvenate the aged thymi. These studies are consistent with our conclusion that host factors extrinsic to the thymus control its involution and suggest that these factors are not provided by the bone marrow.
The effects of the young vs. old milieu on liver and muscle stem cells and on progenitor cells has recently been studied by using parabiotic pairings (20) . The normal decline in tissue regenerative potential with age was shown to be reversed in the older paired mice through exposure to serum factors from young mice. The authors did not, however, examine the involution of the thymi in these studies, possibly because of the potentially confounding effects of having old and young thymi present in the same system. Our thymus transplantation model between MHCmatched recipients provides a model that eliminates this variable while exposing aged thymus to a young milieu.
There have been several studies attempting to characterize the factors in the microenvironment that cause thymic involution. Surgical castration and chemical castration using luteinizing hormone-releasing hormone (LH-RH) have been shown to have a profound rejuvenating effect on the thymus in mammalian models (17, (21) (22) (23) . Additionally, IL-7, produced by MHC class II-positive thymic epithelial cells, has been linked to the survival and proliferation of thymocytes (24) . IL-7 levels decrease with age (25), but whereas thymopoiesis increased in young mice that received IL-7, treatment of aged mice did not augment thymopoiesis (26, 27) . Although the present study demonstrates that extrinsic factors can facilitate thymic regeneration, thus far, no factor has definitively been shown to be directly involved in the involution or regeneration of the thymus.
Data in the present study have also demonstrated that rejuvenated aged VTLs could induce tolerance but require a longer course of immunosuppression to establish tolerance than do recipients of juvenile VTLs. We have previously shown that a 12-day course of FK506 facilitated the induction of tolerance by juvenile VTL grafts across even a full MHC mismatch (13) . Aged VTL grafts required a 28-day course of FK506 to induce tolerance in the class I MHC disparate model studied here. Plausible explanations for the requirement of prolonged immunosuppression include: (i) in aged VTL grafts, there are fewer natural regulatory cells to inhibit alloreactive T cells in a nonspecific manner during the induction period, and (ii) the aged thymic grafts are slower in generating donor-specific regulatory cells and in deleting/anergizing new alloreactive thymocytes. Because T cells were not depleted in the present study, preexisting alloreactive precursor T cells circulating in the blood could enter the VTL graft (28, 29) during the induction period and damage the thymic epithelial and stromal cells. This damage could further inhibit the graft's ability to generate donor-specific antigen-dependent regulatory cells and to delete or anergize alloreactive cells in the graft. Aged VTL grafts that were protected by a 28-day course of FK506 in the induction period had no evidence of vasculitis, indicating that this immunosuppression was sufficient to protect the aged, involuted VTL graft from alloreactive circulating T cells. Thymopoiesis was further delayed by transplanting aged VTLs across a class I mismatch barrier (thymopoiesis occurred after day 60) as compared with across a minor MHC mismatch (near complete conversion to recipient-type thymopoiesis by day 60). The increased immunological response caused by the class I disparity during the induction period may have damaged the thymic epithelial and stromal cells either in number or function, inhibiting thymopoiesis at early time points despite the prolonged course of immunosuppression.
The present study, involving the transplantation of old thymi into young recipients, may provide a model for isolating and examining individual external factors that control the regeneration of thymic capacity. Further decreases in the number of thymic stromal cells by more formidable immunologic barriers (i.e., full MHC mismatch or xenotransplantation) or aged VTL into older recipients, could potentially result in a negative cytokine milieu for the aged VTLs and limit the ability of the VTLs to induce T cell tolerance to donor antigens. We are therefore currently investigating ways to accelerate the regeneration process of aged thymus to facilitate more rapid engraftment and function in these grafts. Preliminary data using Lupron, an LH-RH agonist, suggest that the regeneration of the aged thymus may be possible (K.Y., unpublished data). Medical thymic regeneration, combined with VTL transplantation, could move our tolerance induction regimen one step closer to the clinic by regenerating aged thymus either before or after VTL transplantation into an aged recipient. This strategy could have practical implications for extending thymus-dependent tolerance-inducing protocols (5, 12, 13, (30) (31) (32) to adult patient populations.
Materials and Methods
Animals. Animals were cared for according to the guidelines of Massachusetts General Hospital Institutional Animal Care and Use Committee. MGH miniature swine represent one of the few large animal species in which breeding characteristics make genetic experiments possible (9) . Fifty-three naive animals euthanized as organ donors for other experiments were used for a morphometric study to assess natural thymic involution. Six juveniles (Ͻ6 months of age) and six adults (20-21 months of age) served as donors of VTL transplants in either MHCmatched or class I MHC-mismatched combinations.
Surgical Procedures. Complete thymectomy in the recipient. As described (5), the pretracheal muscles were retracted, exposing the cervical thymus and trachea from the cervicothoracic junction to the mandibular area. The cervical thymus was excised, after which the mediastinal thymus was removed through a sternotomy. VTL transplantation. The procedure for VTL graft transplantation has been reported (13) . Briefly, the right cervical thymic lobe was carefully harvested, perfused with cold Eurocollins solution, and transplanted into the retroperitoneum of recipients, by using the abdominal aorta and the inferior vena cava. This technique led to perfusion of the VTL grafts with an immediate blood supply. Six animals received a 28-day course of FK506, and three animals received a 12-day course of FK506, starting at 0.15 mg/kg per day and adjusted to maintain blood levels between 30 and 40 ng/ml (31) . Thymus biopsy. VTL biopsies were carried out at 0, 60, 100, 180, and Ͼ240 days after VTL transplantation. Renal transplant recipients had thymus biopsies when the experiment was terminated. Approximately 1 ϫ 0.5 ϫ 0.5 cm of thymic tissue was biopsied for histology (formalin and frozen samples) and flow cytometric analysis. The sections of naive thymus used for morphometric analysis were taken from naive pigs that served as organ donors for other studies. Tissue samples were fixed in 1% formaldehyde solution (Denison Pharmaceuticals, Pawtucket, RI), embedded in paraffin, and subsequently sectioned. Tissues were stained by using hematoxylin/eosin (H&E). Kidney transplantation. The kidney transplantation procedure has been reported (5) . Both native kidneys were removed on the day of kidney transplantation. Catheter placement. Two semipermanent, indwelling, Hickman silastic central venous catheters were placed in the external jugular veins to facilitate drug administration and frequent blood sampling for in vitro assays and laboratory tests including complete blood count and blood chemistry, and for monitoring of whole-blood FK506 levels.
Evaluation of Thymic Rejuvenation/Involution. Preparation of thymocytes. Biopsied tissue from thymic grafts (100-200 mg) was finely minced in Hanks' balanced salt solution (HBSS) buffer; the cell suspension was then filtered twice through a 200-m nylon mesh. Flow cytometry. FACS analysis of PBMCs was performed by using a Becton Dickinson FACScan (San Jose, CA) with CellQuest FACStation software (Becton Dickinson) as reported (13) . Phenotypic analysis of cells was attained by three-color staining with directly conjugated murine anti-swine mAbs.
Monoclonal antibodies (mAbs) used for phenotypic characterization of cell populations in VTL grafts. Thymocyte development was assessed by immunohistochemistry and FACS analyses by using the murine anti-swine mAbs 74-12-4 (IgG2b, anti-swine CD4), 76-2-11 (IgG2a, anti-swine CD8), 76-7-4 (IgG2a, anti-swine CD1), BB23-8E6 (IgG2b, anti-swine CD3), 231.3B2 (IgG1, anti-swine CD25), 10-9 (anti-PAA), 2.12.3a (IgM, class I d ), 16.7.E4.2 (IgM, class I c ), and TH16 (IgG2a, anti-swine class II DQ) as reported (8) . Histological analysis. Formalin-embedded tissue was stained by using H&E. Coded samples were examined through a light microscope by a pathologist. Frozen samples were prepared for immunohistochemical analysis with the avidin-biotin horseradish-peroxidase complex technique (30) . Thymopoiesis was assessed by immunohistochemistry by using the swine-specific murine mAbs described above. Double immunostaining with PCNA and cytokeratin (Z622; Dako, Carpinteria, CA) for the identification of the proliferating thymic epithelial cells was performed in formalin-fixed paraffin sections by using a combination of immunoalkaline phosphatase and standard avidin-biotin complex (ABC) technique.
Morphometric analysis. Morphometric studies were performed on thymic biopsy samples by using NIH Image (Scion Image, Frederick, MD) software (10) . Biopsy samples with at least 10 lobules were stained with H&E, and the areas of the cortex and medulla were measured to obtain a c/m ratio in the cross-section of the thymus. Increases in this ratio were taken as a measure of rejuvenation of the thymus. Statistical analysis. Student's t test was used to compare c/m ratios.
In Vitro Cellular Assays. Cell-mediated lymphocytotoxicity (CML) assays.
CML assays were set up before VTL transplantation, and days 30, 60, 90, 150, 180, and Ͼ250. Methods have been described (5) . CD25 depletion CML assays. To test whether anti-donor CTL activity was restored by removal of CD25-positive cells from responders, a CD25 depletion CML was set up with PBL from a long-term acceptor (recipient 6). CD25-positive cells were depleted by magnetic cell separation (MACS; Miltenyi Biotec, Auburn, CA). CD25-negative cells were used as responders and cultured with stimulators in the same manner as in a primary CML. Completion of CD25 depletion was confirmed by FACS analysis. Coculture assays. Peripheral regulatory mechanisms were investigated by in vitro coculture assays (33) . The primary culture was set up as in CML assays. The primed responder cells were then harvested and rested overnight at 4°C, after which they were coincubated with naive SLA-matched PBMCs and irradiated donor-type or third-party PBMCs for 5 additional days.
